verapamil has been researched along with pancuronium in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (71.43) | 18.7374 |
| 1990's | 3 (14.29) | 18.2507 |
| 2000's | 2 (9.52) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dresser, MJ; Giacomini, KM; Gray, AT; Terashita, S; Yost, SC; Zhang, L | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Baeyens, JM; Carlos, R; Del Pozo, E; Ocaña, M | 1 |
| Magnin, C; Neidhart, P | 1 |
| Ilias, W; Steinbereithner, K | 1 |
| Abadir, AR; Agrawal, AK; Gintautas, J; Kraynack, BJ; Lawson, NW | 1 |
| Abernethy, DR; Chelly, JE; Dlewati, A; Doursout, MF; Hill, DC; Merin, RG | 1 |
| Baeyens, JM; Carlos, R; del Pozo, E; Salvador, A | 1 |
| Cohen, G; Dajee, H; Flacke, W; Kapur, PA; Norel, EJ | 1 |
| Wali, FA | 2 |
| Carpenter, RL; Mulroy, MF | 1 |
| Carlos, R; Erill, S | 1 |
| Broadbent, MP; Cashman, JN; Casson, WR; Jones, RM | 1 |
| Dhasmana, KM; Erdmann, W; Kuypers, RS; van Poorten, JF | 1 |
| Gintautas, J; Kraynack, BJ; Lawson, NW; Tjay, HT | 1 |
| Durant, NN; Katz, RL; Nguyen, N | 1 |
| Gintautas, J; Kraynack, BJ; Lawson, NW | 1 |
| Sekerci, S; Tulunay, M | 1 |
1 review(s) available for verapamil and pancuronium
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
20 other study(ies) available for verapamil and pancuronium
| Article | Year |
|---|---|
Cloning and functional expression of a human liver organic cation transporter.
Topics: Amino Acid Sequence; Animals; Base Sequence; Carrier Proteins; Cloning, Molecular; DNA, Complementary; Humans; Liver; Membrane Proteins; Molecular Sequence Data; Oocytes; Organic Cation Transporter 1; Polymerase Chain Reaction; Rats; RNA, Messenger; Sequence Homology, Amino Acid; Species Specificity; Tissue Distribution; Xenopus laevis | 1997 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Differential potentiation by calcium antagonists of neuromuscular blockade induced by pancuronium and succinylcholine in cats in vivo.
Topics: Animals; Calcium Channel Blockers; Cats; Diltiazem; Dose-Response Relationship, Drug; Drug Synergism; Female; Male; Neuromuscular Blocking Agents; Nicardipine; Pancuronium; Stereoisomerism; Succinylcholine; Verapamil | 1992 |
[Prevention of tachycardia induced by a fentanyl-pancuronium combination in the coronary patient: propranolol or verapamil?].
Topics: Coronary Disease; Fentanyl; Humans; Middle Aged; Pancuronium; Propranolol; Tachycardia; Verapamil | 1989 |
Potentiation of pancuronium induced neuromuscular blockade by calcium channel blockers in vitro.
Topics: Animals; Calcium Channel Blockers; Depression, Chemical; Diltiazem; Drug Synergism; Gallopamil; Male; Neuromuscular Junction; Nifedipine; Nisoldipine; Pancuronium; Rats; Rats, Inbred Strains; Synaptic Transmission; Verapamil | 1985 |
Verapamil reduces muscle twitch in chronically treated preparations.
Topics: Animals; In Vitro Techniques; Muscle Contraction; Neuromuscular Junction; Pancuronium; Rana catesbeiana; Synaptic Transmission; Verapamil | 1986 |
Cardiovascular effects of and interaction between calcium blocking drugs and anesthetics in chronically instrumented dogs. VI. Verapamil and fentanyl-pancuronium.
Topics: Animals; Dogs; Drug Interactions; Fentanyl; Hemodynamics; Pancuronium; Verapamil | 1988 |
Differential effects of calcium channel blocking agents on pancuronium- and suxamethonium-induced neuromuscular blockade.
Topics: Animals; Calcium Channel Blockers; Diltiazem; Drug Synergism; Female; In Vitro Techniques; Muscle Contraction; Neuromuscular Junction; Nicardipine; Pancuronium; Rats; Rats, Inbred Strains; Succinylcholine; Verapamil | 1988 |
Haemodynamic effects of verapamil administration after large doses of fentanyl in man.
Topics: Adult; Aged; Anesthesia, General; Blood Pressure; Coronary Artery Bypass; Coronary Disease; Diazepam; Epinephrine; Fentanyl; Hemodynamics; Humans; Middle Aged; Norepinephrine; Pancuronium; Propranolol; Pulmonary Circulation; Stroke Volume; Vascular Resistance; Verapamil | 1986 |
Verapamil intensifies neuromuscular blockade produced by gallamine and pancuronium at the chick neuromuscular junction.
Topics: Animals; Chickens; Drug Synergism; Gallamine Triethiodide; In Vitro Techniques; Muscle Contraction; Neuromuscular Blocking Agents; Neuromuscular Junction; Pancuronium; Verapamil | 1986 |
Edrophonium antagonizes combined lidocaine-pancuronium and verapamil-pancuronium neuromuscular blockade in cats.
Topics: Animals; Cats; Edrophonium; Infusions, Intravenous; Infusions, Parenteral; Injections, Intravenous; Lidocaine; Muscle Contraction; Neuromuscular Junction; Pancuronium; Verapamil | 1986 |
Interaction of verapamil with gallamine and pancuronium and reversal of combined neuromuscular blockade with neostigmine and edrophonium.
Topics: Animals; Chickens; Drug Interactions; Edrophonium; Gallamine Triethiodide; In Vitro Techniques; Muscle Contraction; Neostigmine; Neuromuscular Blocking Agents; Neuromuscular Junction; Pancuronium; Verapamil | 1986 |
Therapeutic rounds: abnormally prolonged responses to neuromuscular blocking agents.
Topics: Apnea; Drug Interactions; Humans; Male; Middle Aged; Neostigmine; Pancuronium; Postoperative Complications; Verapamil | 1986 |
Verapamil potentiation of neuromuscular blockade: failure of reversal with neostigmine but prompt reversal with edrophonium.
Topics: Anesthesia; Cardiomyopathy, Hypertrophic; Cholecystectomy; Drug Synergism; Edrophonium; Humans; Male; Middle Aged; Neostigmine; Neuromuscular Junction; Pancuronium; Tubocurarine; Verapamil | 1985 |
Verapamil and reversal of vecuronium neuromuscular blockade.
Topics: Aged; Anesthesia; Drug Interactions; Female; Humans; Neuromuscular Blocking Agents; Neuromuscular Junction; Pancuronium; Synaptic Transmission; Vecuronium Bromide; Verapamil | 1984 |
Effects of verapamil on indirect muscle twitch responses.
Topics: Animals; Drug Interactions; Electric Stimulation; In Vitro Techniques; Muscle Contraction; Neuromuscular Junction; Pancuronium; Rana catesbeiana; Verapamil | 1983 |
Potentiation of neuromuscular blockade by verapamil.
Topics: Animals; Blood Pressure; Bungarotoxins; Dose-Response Relationship, Drug; Drug Synergism; Electrocardiography; Heart Rate; Male; Muscle Contraction; Muscles; Neuromuscular Blocking Agents; Pancuronium; Rabbits; Succinylcholine; Verapamil | 1984 |
Neuromuscular and electrocardiographic responses to verapamil in dogs.
Topics: Animals; Calcium Channel Blockers; Dogs; Electrocardiography; Heart; Heart Conduction System; Heart Rate; Hemodynamics; Muscle Contraction; Neuromuscular Junction; Pancuronium; Procaine; Verapamil | 1983 |
Interactions of calcium channel blockers with non-depolarising muscle relaxants in vitro.
Topics: Animals; Atracurium; Calcium Channel Blockers; Culture Techniques; Dose-Response Relationship, Drug; Drug Interactions; Male; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Nicardipine; Pancuronium; Rats; Vecuronium Bromide; Verapamil | 1996 |